Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Entervax (ZH9 + ZH9PA) in Healthy Participants
NCT04349553Phase 1Completed
- Sponsor
- Prokarium
- Start
- Dec 2019
- Primary completion
- Sep 2020
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of M01ZH09 in enteric fever (4 arms), sponsored by Prokarium. Primary endpoints: Treatment Emergent Adverse Events and Abnormal Clinically or Non-clinically Significant Tests. Started Dec 2019; status: completed.
02
Drugs
M01ZH09
03
Conditions
enteric fever
Beyond the preview
Go deeper on NCT04349553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349553.